Fenretinide in Healthy Young Women at Genetic and Familial Risk

NCT01479192 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped very low rate of patient accrual

Conditions

High-Risk Cancer

Interventions

DRUG: Fenretinide
OTHER: Placebo

Sponsor

European Institute of Oncology